Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA).

N Z Haque1, S L Davis, C L Manierski

  • 1Henry Ford Health System, Detroit, MI, USA.

International Journal of Antimicrobial Agents
|April 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape study.

ESMO open·2025
Same author

Decision-making in women who considered planned oocyte cryopreservation: decision satisfaction or regret?

Reproductive biomedicine online·2025
Same author

Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study.

The British journal of surgery·2021
Same author

Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.

Antimicrobial agents and chemotherapy·2019
Same author

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.

Journal for immunotherapy of cancer·2019
Same author

Immune and autoimmune-related adverse events associated with immune checkpoint inhibitors in cancer therapy.

Drugs of today (Barcelona, Spain : 1998)·2018

Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA) is increasingly seen in urban settings, particularly among injection drug users. This highlights the need for heightened clinical awareness and tailored prevention strategies for this evolving pathogen.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Microbiology

Background:

  • Infective endocarditis (IE) is a serious infection of the heart's inner lining.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen, with the USA300 strain becoming increasingly prevalent.
  • Injection drug use is a known risk factor for developing IE.

Observation:

  • This study details seven cases of IE attributed to USA300 MRSA at an urban academic medical center.
  • All affected patients were identified as injection drug users.
  • The isolates were confirmed as USA300-type MRSA using pulsed-field gel electrophoresis.

Findings:

  • Five cases involved right-sided endocarditis, and two involved left-sided endocarditis.
  • Patients received prolonged antimicrobial therapy, averaging 23 days in-hospital and 55 days total.

Related Experiment Videos

  • Complications included heart failure, requiring valve replacement in one case, and mortality in that same patient.

    • Implications:

    • The rising prevalence of USA300 MRSA necessitates increased clinical vigilance for IE, especially in at-risk populations.
    • Understanding the spectrum of illness associated with USA300 MRSA IE is crucial for effective management.
    • Enhanced prevention strategies are needed to address the growing threat of this virulent MRSA strain.